Comparative Impact of Rotavirus and HPV Vaccination in GAVI Countries
Author Information
Author(s): Kim Sun-Young, Sweet Steven, Chang Joshua, Goldie Sue J
Primary Institution: Harvard School of Public Health
Hypothesis
How can the comparative impact of different new vaccines be assessed in resource-poor settings?
Conclusion
Both rotavirus and HPV vaccines can save a similar number of lives over the target populations' lifetimes, but the timing of these benefits differs significantly.
Supporting Evidence
- Rotavirus vaccination could prevent approximately 274,000 deaths among vaccinated cohorts.
- HPV vaccination could prevent approximately 286,000 cervical cancer deaths among the target population.
- Both vaccines are considered cost-effective in most GAVI-eligible countries.
- Vaccination with rotavirus is more resource-intensive than HPV due to the need to vaccinate both genders.
Takeaway
This study looks at how two vaccines, one for rotavirus and one for HPV, can help save lives in poorer countries, showing that both are important but work in different ways.
Methodology
The study compared health, economic, and financial consequences of introducing rotavirus and HPV vaccines in 72 GAVI-eligible countries using static models.
Potential Biases
The study's reliance on standardized assumptions may skew estimates of vaccine benefits.
Limitations
The analysis relies on standardized assumptions and does not capture potential herd immunity effects, which may underestimate the true impact of the vaccines.
Participant Demographics
The target populations included infants for rotavirus vaccination and pre-adolescent girls for HPV vaccination.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website